Two Sigma Securities LLC lessened its stake in Strategy Incorporated (NASDAQ:MSTR - Free Report) by 78.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,063 shares of the software maker's stock after selling 3,869 shares during the period. Two Sigma Securities LLC's holdings in Strategy were worth $308,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of MSTR. Garden State Investment Advisory Services LLC grew its stake in Strategy by 1,005.0% in the 3rd quarter. Garden State Investment Advisory Services LLC now owns 2,630 shares of the software maker's stock worth $443,000 after buying an additional 2,392 shares in the last quarter. Virtu Financial LLC boosted its stake in shares of Strategy by 10,398.4% in the 3rd quarter. Virtu Financial LLC now owns 224,245 shares of the software maker's stock valued at $37,808,000 after purchasing an additional 222,109 shares in the last quarter. Peapack Gladstone Financial Corp boosted its stake in shares of Strategy by 900.0% in the 3rd quarter. Peapack Gladstone Financial Corp now owns 2,350 shares of the software maker's stock valued at $396,000 after purchasing an additional 2,115 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Strategy by 3.3% in the 3rd quarter. Franklin Resources Inc. now owns 4,248 shares of the software maker's stock valued at $716,000 after purchasing an additional 135 shares in the last quarter. Finally, Beaird Harris Wealth Management LLC boosted its stake in shares of Strategy by 1,105.2% in the 3rd quarter. Beaird Harris Wealth Management LLC now owns 4,640 shares of the software maker's stock valued at $782,000 after purchasing an additional 4,255 shares in the last quarter. Hedge funds and other institutional investors own 59.84% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on MSTR shares. Cantor Fitzgerald upped their price objective on shares of Strategy from $613.00 to $619.00 and gave the company an "overweight" rating in a research note on Thursday, February 6th. Benchmark reissued a "buy" rating and set a $650.00 price target on shares of Strategy in a research report on Tuesday, January 14th. Keefe, Bruyette & Woods assumed coverage on shares of Strategy in a research report on Friday, February 7th. They set an "outperform" rating and a $560.00 price target for the company. Monness Crespi & Hardt cut shares of Strategy from a "neutral" rating to a "sell" rating and set a $220.00 price target for the company. in a research report on Tuesday, April 1st. Finally, Barclays dropped their price target on shares of Strategy from $515.00 to $421.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $508.09.
View Our Latest Research Report on MSTR
Insiders Place Their Bets
In other Strategy news, CFO Andrew Kang purchased 1,500 shares of the business's stock in a transaction on Thursday, March 20th. The stock was acquired at an average price of $85.00 per share, for a total transaction of $127,500.00. Following the purchase, the chief financial officer now owns 1,500 shares of the company's stock, valued at approximately $127,500. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jarrod M. Patten sold 1,700 shares of the firm's stock in a transaction dated Tuesday, April 22nd. The shares were sold at an average price of $342.01, for a total value of $581,417.00. Following the transaction, the director now owns 4,970 shares of the company's stock, valued at approximately $1,699,789.70. The trade was a 25.49 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders acquired 8,000 shares of company stock worth $680,000 and sold 34,698 shares worth $11,403,343. 9.16% of the stock is currently owned by company insiders.
Strategy Trading Up 0.1 %
NASDAQ:MSTR opened at $369.25 on Tuesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.71 and a quick ratio of 0.65. The firm has a market capitalization of $95.03 billion, a price-to-earnings ratio of -65.55 and a beta of 3.46. Strategy Incorporated has a one year low of $101.00 and a one year high of $543.00. The business has a fifty day moving average price of $296.58 and a 200-day moving average price of $318.45.
Strategy (NASDAQ:MSTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The software maker reported ($3.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by ($3.07). Strategy had a negative return on equity of 19.01% and a negative net margin of 251.73%.
Strategy Company Profile
(
Free Report)
Strategy Incorporated, formerly known as MicroStrategy, provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers Strategy ONE, a platform that allows non-technical users to access novel and actionable insights for decision-making, and Strategy Cloud for Government, which provides always-on threat monitoring designed to meet the strict technical and regulatory standards of governments and financial institutions.
Recommended Stories
Want to see what other hedge funds are holding MSTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Strategy Incorporated (NASDAQ:MSTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Strategy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Strategy wasn't on the list.
While Strategy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.